2011
DOI: 10.1378/chest.11-0525
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
10
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 42 publications
0
10
0
Order By: Relevance
“…The importance of this fact is stressed by the observation that inhalational administration of this drug, which should theoretically reduce its systemic effects [12], is associated electrophysiological influence on myocardial cells [13]. Data about clinical significance of this finding are conflicting stating that beta mimetics can increase the risk of cardiac morbidity among patients with chronic obstructive pulmonary disease [14] as well as that there is no influence of bronchodilatory treatment among critically ill on heart rate (HR) and incidence of arrhythmias [15]. It is also noticeable that most of the studies about this topic do not cover the ICU population.…”
Section: Study Registered At Clinicaltrialsgov Trial Registry Numbementioning
confidence: 99%
“…The importance of this fact is stressed by the observation that inhalational administration of this drug, which should theoretically reduce its systemic effects [12], is associated electrophysiological influence on myocardial cells [13]. Data about clinical significance of this finding are conflicting stating that beta mimetics can increase the risk of cardiac morbidity among patients with chronic obstructive pulmonary disease [14] as well as that there is no influence of bronchodilatory treatment among critically ill on heart rate (HR) and incidence of arrhythmias [15]. It is also noticeable that most of the studies about this topic do not cover the ICU population.…”
Section: Study Registered At Clinicaltrialsgov Trial Registry Numbementioning
confidence: 99%
“…Several recent studies evaluating levalbuterol in pediatric or critically ill patients have reported results similar to the findings of our analysis. 32,37 Additionally, our study only evaluated the short-term use of inhaled nebulizers for treatment of acute exacerbations. Many patients use metered-dose inhalers containing levalbuterol or albuterol on a fairly regular basis for chronic disease control.…”
Section: Comparative Data On Total Treatment Costs ($) Stratified By mentioning
confidence: 99%
“…22 Khorfan et al assessed the effects of albuterol or levalbuterol treatment in critically ill patients with acute airflow obstruction, and reported no significant tachycardia or tachyarrhythmias when recommended doses were used for both agents. 21 Seven new arrhythmias occurred (.8%) in 878 treatments, and most of them were transient atrial and ventricular arrhythmias, with only 1 episode of atrial fibrillation. Levalbuterol may induce more arrhythmias because of its more potent b 2 -agonist effect, but some patients may require a higher dose of albuterol than levalbuterol during acute bronchospastic events, which may predispose them to more arrhythmias.…”
mentioning
confidence: 99%
“…Some studies reported increased arrhythmias, such as tachycardia, with bronchodilator treatment, whereas others found no difference in the precipitation of arrhythmia. [19][20][21][22] The arrhythmogenic effects of albuterol and levalbuterol have been evaluated in the literature. Although a similar increase in heart rate for both agents was reported, albuterol treatment at high doses led to a higher serum level of R-albuterol and a higher mean heart rate, compared with levalbuterol.…”
mentioning
confidence: 99%
See 1 more Smart Citation